On Monday 29 December 2025, Azenta, Inc. announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement to sell its B Medical Systems business to THELEMA Sarl for a purchase price of $63 million (€58 million), with the transaction expected to close on or before 31 March 2026.
The transaction concerns B Medical Systems Sarl, a Luxembourg-based market leader in temperature-controlled storage and transportation solutions that enable the delivery of life-saving treatments worldwide, along with its subsidiaries.
"The agreement to sell B Medical Systems marks a major step forward in simplifying the portfolio to prioritize our core capabilities with the highest strategic impact," said John Marotta, President and CEO of Azenta. "The proceeds from this sale will be deployed to strengthen the company and drive long-term profitable value creation for our shareholders.”
According to the company, William Blair served as exclusive financial advisor, while Taylor Wessing acted as legal counsel for the transaction.
Azenta, Inc. (Nasdaq: AZTA) is a global provider of life sciences solutions, supporting life science organisations worldwide in bringing scientific breakthroughs and therapies to market more efficiently.
